Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Athanase Innovation AB's enterprise value is kr393.19 Mil.
Athanase Innovation AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was kr192.77 Mil. Therefore, Athanase Innovation AB's EV-to-EBITDA for today is 2.04.
The historical rank and industry rank for Athanase Innovation AB's EV-to-EBITDA or its related term are showing as below:
OSTO:ATIN's EV-to-EBITDA is not ranked *
in the Asset Management industry.
Industry Median: 8.465 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Athanase Innovation AB (OSTO:ATIN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Athanase Innovation AB's PE Ratio (TTM) for today is calculated as:
Athanase Innovation AB's share price for today is kr20.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athanase Innovation AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was kr945.104.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ATIN vs EVG, SMM, NHS: EV-to-EBITDA Comparison
For the Asset Management subindustry, Athanase Innovation AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athanase Innovation AB EV-to-EBITDA vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Athanase Innovation AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Athanase Innovation AB's EV-to-EBITDA falls into.
Athanase Innovation AB's current Enterprise Value is kr393.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athanase Innovation AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was kr192.77 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Athanase Innovation AB (OSTO:ATIN) has a EV-to-EBITDA of 2.04 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Athanase Innovation AB.
Is Athanase Innovation AB's EV-to-EBITDA too high?
Athanase Innovation AB's current EV-to-EBITDA is 2.04. The Asset Management industry median EV-to-EBITDA is 8.47. Athanase Innovation AB's value of 2.04 is 75.9% below this industry median. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's EV-to-EBITDA compare to EVG and SMM?
Athanase Innovation AB's EV-to-EBITDA of 2.04 can be compared against companies in the Asset Management industry. The industry median EV-to-EBITDA is 8.47. Athanase Innovation AB's value of 2.04 is 75.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for an Asset Management company?
The median EV-to-EBITDA among Asset Management companies is 8.47, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Athanase Innovation AB's current EV-to-EBITDA of 2.04 is 75.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Athanase Innovation AB. For the Asset Management industry, the median EV-to-EBITDA is 8.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athanase Innovation AB's current EV-to-EBITDA is 2.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current EV-to-EBITDA of 2.04. The current EV-to-EBITDA is 2.04 and 75.9% below the Asset Management industry median of 8.47. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current EV-to-EBITDA is 2.04 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score
Get the complete analysis for OSTO:ATIN
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ATIN has been successfully added to your 
